It should be recognized that the Glinsky cohort does not provide information on the gene expression in normal tissue from the cancer patients, or healthy individuals that have increased PSA independent of cancer occurrence, thus the current gene signatures are indicative of prognostic potential rather than necessarily stratifying healthy individuals from those with prostate cancer. This evidence concerns the gene KLK3 and prostate cancer.